Neuromuscular Study Group is ranked among medical research organizations in Kansas City, KS, with an America's Best Score of 62 out of 100, based on its 2024 Form 990.
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$588,959Fiscal year 2024
Expenses$519,092Fiscal year 2024
Total assets$530,512Fiscal year 2024
Total liabilities$0Fiscal year 2024
Fiscal year ending December2024
Revenue$588,959
Expenses$519,092
Net income$69,867
Net assets$530,512
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$580,823
98.6%
Investment income
$8,136
1.4%
Other (net)
$0
0.0%
Assets / debt
Total assets
$530,512
Total liabilities
$0
Net assets
$530,512
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$434,016
Expenses$462,062
Net income−$28,046
Net assets$460,644
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$428,105
98.6%
Investment income
$611
0.1%
Other (net)
$5,300
1.2%
Assets / debt
Total assets
$460,644
Total liabilities
$0
Net assets
$460,644
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$278,605
Expenses$425,917
Net income−$147,312
Net assets$488,693
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$278,605
100.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$488,693
Total liabilities
$0
Net assets
$488,693
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?